Revolutionizing Assistive Technology: Myant and Coapt Join Forces for Advanced Solutions

Myant and Coapt's Innovative Partnership

In an impressive collaboration set to reshape the landscape of assistive technology, Myant Corp. and Coapt have announced their strategic partnership aimed at enhancing patient care through cutting-edge textile computing and neural interface technologies. Both companies share a strong commitment towards improving quality of life for individuals using assistive devices, particularly prosthetics.

The innovation centers around the development of textile-based electromyography (EMG) interfaces. By merging Coapt’s advanced EMG intent decoder control systems with Myant's pioneering textile technologies, this partnership aims to deliver new products that promise greater comfort, precision, and control for users of prosthetic limbs and related therapeutic devices.

Transformative Outcomes for Users

The collaboration isn't just about technological advancement; it's about changing lives. The introduction of these new products may lead to significant improvements in managing phantom limb pain and offering biofeedback-based solutions. This aligns beautifully with Myant's overarching mission to enhance everyday experiences for individuals with unique needs.

Tony Chahine, CEO of Myant, expressed enthusiasm about the partnership, stating, "Myant and Coapt share a vision of improving quality of life through seamless integration between technology and the human body." He believes that this collaboration will push the boundaries of what is possible in the realms of prosthetics and rehabilitation.

The roadmap for this initiative includes exploring virtual and augmented reality applications for medical therapies. Both companies plan to engage in funded research and clinical trials to investigate the broader implications of their technologies, thus more effectively addressing patients' needs globally.

Future Innovations and Product Launches

Blair Lock, CEO of Coapt, shared his optimism about the potential of this partnership, highlighting, "Together, Coapt and Myant are creating a future where assistive technology not only helps people regain function, but also improves their overall comfort and autonomy." This statement underscores a crucial aspect of modern medical technology: the focus on patient experience and empowerment.

The unveiling of their advancements is slated to occur at the upcoming Consumer Electronics Show (CES) from January 7-10, 2025, in Las Vegas. Both Myant and Coapt plan to demonstrate their latest innovations live, aiming to accelerate the adoption of next-generation assistive solutions and create meaningful connections within the global healthcare community.

About Myant and Coapt

Myant is committed to enhancing quality living through the integration of AI, advanced materials, and healthcare innovation. They are leading a new era of textile computing where textiles function seamlessly as a second skin, allowing for continuous health monitoring and health management.

On the other hand, Coapt, based in Chicago, specializes in advanced prosthetic control systems. Since its inception in 2012, Coapt has developed the Complete Control system, which utilizes machine learning to help users control their prosthetic limbs effortlessly. This technology works seamlessly with various limb configurations, making it a versatile solution in the field of prosthetics.

Together, these two companies aim to set new standards for assistive technologies, ultimately transforming the lives of individuals who rely on such innovations. The future looks promising as they continue to explore new technologies and applications that will lead to improved outcomes for their users.

Conclusion

The partnership between Myant and Coapt represents a significant step forward in assistive technologies. With a shared goal of enhancing the quality of life for individuals using these devices, their collaboration is poised to deliver transformative experiences for users and professionals alike. As they prepare to showcase their innovations at CES 2025, the potential for positive change in the healthcare landscape remains immeasurable.